(Q27005840)

English

Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer

scientific article

In more languages

Statements

scholarly article

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Marinus Blankenstein

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Annemieke C Heijboer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Tim M van der Sluis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

André N Vis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R Jeroen A van Moorselaar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hong N Bui

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Eric J H Meuleman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

1 reference

publication date

12 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

BJU International

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

109

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

176-182

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21992222%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Determination of prostatic androgens in 10 mg of tissue using liquid chromatography-tandem mass spectrometry with charged derivatization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Liquid chromatography-mass spectrometric assay of androstenediol in prostatic tissue: influence of androgen deprivation therapy on its level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Standardization of testosterone measurements in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Immunoassays for testosterone in women: better than a guess?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Toward excellence in testosterone testing: a consensus statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Subnormal Tissue 3α-Androstanediol and Androsterone in Prostatic Hyperplasia*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of Megestrol Acetate (Megace®) on Steroid Metabolism and Steroid-Protein Binding in the Human Prostate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The androgen axis in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Persistent intraprostatic androgen concentrations after medical castration in healthy men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Comparison of dihydrotestosterone levels in prostatic cancer metastases and primary prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10651.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27005840&oldid=1856108826"